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Today, there are multiple well-known examples of implantable medical devices on the market, 
including the cochlear implant, the cardiac pacemaker and the deep brain stimulator. For example, 
for the cochlear implant, a microprobe placed in the auditory nerve is used to transfer sound to 
electrical stimuli to restore hearing. The type of medical device implants that interface the body’s 
neural tissue with recording or stimulating electrodes (also referred to as microprobes) with the 
purpose to regain or restore control of lost or impaired functions is relatively new. They have been 
considered to have particular strong ethical implications1. Although the aim of the technology is to 
restore and rehabilitate, there is a real risk of derive, i.e. new computer technologies possess the 
possibility to be used for enhancement purposes.   
From an ethical point of view, special attention has been given on a particular sub-group of medical 
devices, i.e. those who are ICT based (i.e. ‘’devices using information and communicat ion 
technologies usually based on silicon chip technology‘’), active (i.e. ‘’relying for it’s functioning on 
an internal and independent source of electrical energy or any source of power other than directly 
generated by the human body or gravity procedure‘’ ) and online (i.e. ‘’ICT implants that rely on 
their operation on a connection to an external computer or which can be interrogated by an external 
computer‘’)2.   
Within the EU funded project ‘’EPIONE’’ the objective was to develop and compare the efficiency 
of novel implantable or non-invasive technological solutions as a therapy for phantom limb pain. In 
this project, peripheral nerve electrodes were implanted in the severed nerves in the stump of the 
amputee to transfer electrical stimuli to restore / create natural, meaningful somatic sensations. The 
implantable interface system suggested by the EPIONE project for treatment of phantom limb pain 














Novel medical devices are often driven by academia through private or public funded research and 
development projects over many years, before private companies take over the commercialization of 
the medical products. In academia, the key driving factors for the researchers are not only to find a 
device that can offer a cure, but also seeking new and novel inventions that often are required by 
funding organizations. As such, working within this field implicates that you as a researcher very 
often are choosing unknown paths where the techniques and technologies are in a phase where they 
are not yet legally approved, or perhaps not accepted by the general society.  However, development 
of novel implanted devices is also associated with high risks-high gains for other involved 
stakeholders. In particular, risks are taken by the ‘first-in-human’ patients, i.e. when the technology 
must be transferred from bench-top or in-vivo animal tests to human clinical trials in order to obtain 
a CE-mark, but the patients may be the firsts to benefit from a possible promising treatment. Finally 
development of new medical devices EU and national laws has to be respected, including the EU 
medical device directive (the 90/385/EEC for active implantable devices) national/local ethical 
committees and competent authorities. These rules and regulations are primarily defined to secure 
that the devices are safe for the patients.  
As researchers we may therefore be ‘’caught’’ between a wish to develop new devices with a real 
capability of helping people with disabilities, a need to respect the law, the patient’s hope of an 
available and effective treatment in the near – and a general fascination of the technology and its 
potentials often driven by the public press. As such, the challenge that we faced within the EPIONE 
project was that the required ethical assessment, to tackle, e.g., problems such as the Collingr idge 
dilemma3 or the burden of responsibility4,5 in this particular setting, needed to incorporate both ethical 















Studies in the field of biomedicine show that it is important that ethical awareness and reflection are 
extended beyond the decision on a particular cause of action to allow the decision makers to express 
and evaluate the moral reasoning that enables, warrants and affirms the decision they are faced with7,8 . 
Further, studies also indicate that the quality and competence of such reasoning is enhanced when the 
participants can combine their ordinary or popular moral views and attitudes with concepts and 
positions from ethical theories or normative ethics9,10.  
Therefore, we hypothesized that selected activities could be the instrument needed to promote the 
researcher’s engagement and facilitate a framework for ethical reflection on their own research from 
regulatory, legal and scientific perspectives.  
In this article we, representing both a researcher and an ethicist, look closer at the EU funded EPIONE 
project as an actual research case. An Independent Ethical Advisor (IEA) with a regulatory and 
advisory role was assigned to the project. We utilized the IEA as a means to facilitate and support the 
participating EPIONE researchers in the process navigating within the ethical field of medical 
devices. We suggest a novel framework based on action research where we draw in elements and 
theory related to the interdisciplinary learning environment for building ethical assessment and 




















Introduction to the case – the EPIONE research project 
The research project in the present case was the ‘Natural sensory feedback for phantom limb 
modulation and therapy’ referred to by the acronym EPIONE (project No 602547, FP7-Health-2013-
Innovation programme). This project was coordinated from Aalborg University, Denmark and 
included 12 partners (Denmark, Sweden, France, Germany, Spain, Italy and USA). The objective of 
the project was to develop and compare the efficiency of novel, dedicated technological solutions to 
actively create natural, meaningful sensations as a therapy for phantom limb pain. Phantom limb pain 
(PLP) is a frequent consequence of amputation, spinal cord injury or peripheral nerve damage. PLP 
is notoriously difficult to treat, likely because the understanding of the underlying pathophysiologica l 
mechanisms responsible for PLP is poor. In 50-80% of amputees, neuropathic pain develops in the 
lost limb, which is also referred to as phantom limb pain (PLP)11. Recent evidence suggests, that PLP 
may be related to plastic changes of the neurons in the brain. In EPIONE we aimed to build novel 
and innovative technological pre-industrial systems for delivering invasive/non- invasive sensory 
feedback to compare an invasive and a non-invasive route for delivering sensory feedback to offer 
more long-term or permanent therapies for amputees suffering from phantom limb pain12.  
• Route 1: Direct peripheral nerve sensory feedback. Multiple transverse, intrafascicula r 
electrodes (TIME-4H) were implanted in the median and/or ulnar nerves of volunteer amputee 
subjects. Electrical stimulation was delivered through the active sites by the multi-channe l, 
miniaturized electrical stimulator placed outside of the body. The TIME-4H electrodes were 
surgically removed after completion of the study. To deliver the electrical stimulat ion 
sequences and to obtain quantitative and qualitative measures on the effect of the 














• Route 2: Non-invasive sensory feedback. Either mechanical sensory feedback (i.e., air 
pressure) through silicone pads, or electrical stimulation was applied through off-the-shelf 
electrodes. We used a computerized psychophysical testing platform to deliver stimuli and 
obtain the patient’s response, and we statistically analysed the results14. 
One volunteer participated in receiving ‘direct’ peripheral sensory feedback15, and 8 volunteer 
subjects participated in the non-invasive trials.  
 
The IEA 
All funded EU projects within the HEALTH programme under the 7th framework program that 
included human volunteer subject in clinical trials was legally required to appoint an Independent 
Ethical Advisor (IEA). The overall obligation for the IEA was to ensure that the work within the 
project was conducted in accordance with relevant guidelines and legislation (i.e. a regulatory 
function), and that during the project ethical awareness and reflection was carried out as a committed 
and integrated part of the project (i.e. an advisory function)16. That meant that the IEA supervised: 1) 
that the research followed the ethical EU-guidelines on medical research, as well as the general 
principals of bio-ethics, and 2) that there was substantial ethical consideration within the project 
consortium, including application of a precautionary principle and informed consent, and significant 
ethical analysis and reflections. 
 
Action research approach 
In the field of methodology there is a branch broadly called action research. From its early departure 
in the work and writing of Kurt Lewin, the methodology as well as the methods it carries has evolved 
in numerus fashions. However, there is a strong emphasis on action research investigating, and 














more philosophically oriented thinkers in the field, like Olav Eikeland, has drawn distinctive parallels 
and comprehensions between actions research and the concept of phronesis (ethical reasoning) in 
Aristotle18, supporting the idea of action research being both an investigator and a developer of an 
ethical rationality in practice. Adding to this is the action research approach of Greenwood and 
Levin19 that emphasises the participatory and collaborative approach to both the goals and the means 
of action research initiatives.  
As we implemented the approach of action research we focused on a variety of initiatives and actions, 
and made sure to give them the consecutive structure that should provide an adequate time for 
elaborative development of awareness and attitude, as well as the saturation of qualitative justificat ion 
of actions and processes of change.  These are: 1) the use of informed consent; 2) a survey amongst 
the research partners; 3) a workshop session; 4) observation of consortium meetings; and 5) an 
interview with a participating patient. 
The initiatives were within the action research framework, a way for us to express and facilita te 
“multilevels of ethics”. By multilevels of ethics we mean that ethics have several layers or levels 
ranging from awareness to reflection, including related but also diverse elements such as regulat ion, 
assessment and deliberation, as well as elements ranging from more concrete to more abstract levels. 
From this perspective ethics is viewed as an integrated part of moral life20,21, rather than as an 
argumentative or discursive practice. It is also allowing ethics to have a developmental character in a 
way related to similar level- or stages- learning theories like the SOLO taxonomy22. This opened for 
an interpretation of the action research framework that included a perspective of learning and learning 
theories.  
 














The useful link between the action research approach to ethics in EPIONE and the idea of a learning 
development we found was in the construction of an interdisciplinary learning environment. From 
the literature on interdisciplinarity, we draw out three important characteristics. First, it is a synthes is 
or merger of different disciplines; second, it is embedded in and integrated with a non-academic 
reality; and third, it is problem-oriented23–25. To grasp the ethical perspective as an interdisciplinary 
activity punctuates that it is a way of thinking that on the one hand requires capabilities like those of 
disciplines, such as analysis, theories and objectivism, but on the other hand is not a discipline in 
itself but should be merged with the scientific discipline of one’s own.  
To motivate such an approach, we need the other two characteristics. To acknowledge the 
embeddedness of a scientific project is to understand and adhere to motifs, intensions, interests and 
demands from others, which forces us to comprehend the scientific project on a larger scale, as an 
integrated part of the world, and not as something isolated and contained. Frodeman summarizes all 
these elements into one concept, that of audience, making a distinction between the scientific 
activities that is preforming for themselves, i.e., purely academic pursuits and evaluations, and the 
scientific activities that are more applied and are preforming for an audience outside of academia25. 
Here is where the problem orientation becomes relevant. The claim is that the problems of the world 
are not equivalent to fitting neatly into the disciplinary categories of the departments and faculties of 
science; being problem-oriented means to not just see a disciplinary defined object of study. This 
way, although ethics is external to the disciplinary point of view, ethics is incorporated into the 
motivation and execution of the scientific project as a natural aspect of a problem orientation.26 
The approach also allows us to be focused on creating spaces for active involvement, using group 
dynamics to generate a collaborative deliberation that forces the moral considerations to move in 














(the ethical perspective of others and the normative theories of moral philosophy) and to emerge as 





















EPIONE is a research project that included human volunteer subjects. Therefore, EPIONE is required 
to enrol patients as participants for their research experiments, trials and observations. Recruit ing 
human subjects for such use can only be admissible if the acceptance of enrolment is undertaken by 
the procedure of informed consent. In short, this means that the project partners in EPIONE all must 
inform the patients of the project and ensure their consent, before using them for research purposes. 
The IEA collected documentation of informed consent that the different partners had drawn up and 
had received approval by their local authorities. The documentation concerned the research trials 
carried out in Sweden, Denmark, United States of America, Italy and Switzerland. 
The IEA analysis of all the informed consent documents showed that they all adhered to a general set 
of requirements for ethical assessment29 as follows: 
• The information about the research project and participation in the research was presented in 
a clear and objective manner, avoiding persuasive and manipulative language 
• The information about the research project and participation in the research was presented in 
such a way that a non-health care professional could, without any special knowledge or 
specific ability, comprehend the text and interpret the consequences and conditions for 
participation. 
• The information about the research project and participation in the research included the 
following: 
o Details about the process 
o An assessment of the potential risks 














o Procedures for confidentiality  
o Description of the possibility for termination of participation on the research subject’s 
own initiative. 
• It was made perfectly clear that participation in the research project was voluntary and that 
withdrawal of participation had no negative effects on current treatment or access to future 
treatment opportunities. 
The analysis also showed that the informed consent documents differed in length and structure 
between partners and countries. Some were more formal (strict and bureaucratic language), whereas 
others were more informal (inviting or personal language). Some included quite detailed scientific 
information about the research, while others had less emphasis on the science behind the research 
project. The documents from Sweden differed from the other ones on one important point. The 
Swedish researchers collected an informed consent for each individual procedure or separate trial, 
while the other institutions used only one informed consent form, where the different elements of the 
research, trials, interviews and observations were made clear as part of the information package.  
These differences indicated diversity in customs and traditions between countries, and we can call 
them cultural, but as such they are also moral, and therefore merit an ethical reflection. It was clear 
that some informed consent forms were constructed in a more paternalistic setting, with the 
researchers in a clear authoritarian position. Others approached patients in, what we today might refer 
to, a nudging fashion, and asked the potential participant to engage having the positive outcomes in 
mind. Some took this a step further, and were examples of the commodification of health care with 
an almost seller-buyer communication strategy.  
These differences definitely showed a shift in the researcher – patient relationship, and also in the 
value structure between participants, products and means of this kind of project. These cultura l 













indication of international collaborations need for understanding that general principals and abstract 
concepts cannot escape a more culturally flavoured comprehension. To avoid misunderstandings and 
potential harmful or unfruitful situations these differences called for further deliberative articulat ion 
of moral values and assumptions amongst participations across the inter-cultural landscape, even 
when there seemed to be consensus on the core principals and ethical regulations.   
One other thing that raised concern regarding the information package presented to the volunteer 
subjects were that they all directly emphasized the benefits of the research, both for the participat ing 
individual and the overall outcome, The benefits were presented in a such a way that made them 
appear to be quite reachable, which may have indirectly persuaded patients despartely seeking for a 
treatment while being susceptible to ignore the risk assessments. 
In general, the practice of applying the informed consent in EPIONE followed the established norms 
and regulations. The documentation showed that moral themes like autonomy, precautionary 
principle, and humanity were appreciated, as well as the four guiding principles from principlism. 
The researchers appeared to be thoughtful, open and respectful in their approach to and relationship 
with the participating research subjects. However, the heavy emphasis on benefits may be viewed as 




A survey was conducted among the research partners in EPIONE. The purpose of the survey was to 
establish a common ground for the ethical aspects regarding the research and research process within 
the project and the researchers’ initial reflections and attitudes towards these perspectives. The survey 
consisted of eight questions in total, to which the respondent answered by ranking a list of possible 














comment or to elaborate. The survey also asked for some biographical information. The survey was 
distributed by a link. The data from the survey were stored and analysed in accordance with the codes 
of conduct and legislation for confidentiality, agreed upon between Aalborg University and 
Datatilsynet (Danish governmental agency overseeing the treatment of research data). 
The survey was distributed to 25 participants, with 14 responding in full and 2 giving a partial 
response, resulting in a total of 64% response. Nine institutions were represented. There was an even 
distribution in terms of age groups, and there was an 86% male 14% female ratio. The demographic 
information also showed that 86% had attended an academic seminar, course or workshop in bioethics 
and that 2 of the people who answered the survey had written or presented papers with an emphasis 
on ethical content. 
In the questions, the responders were confronted with evaluating principles, motivations, oversight 
and moral practices regarding their work and participation in EPIONE. They were also asked to rank 
the importance of different forms of moral phenomena to establish their basic approach to init ia te 
moral reflection and ethical awareness. 
The questions were directly or indirectly connected to both principlism- and character-based ethics, 
but none went into any explicit ethical theory or demanded knowledge of normative ethics. All four 
themes from the initial considerations were represented in the questions. 
The main outcomes of the survey were;  
• Autonomy was regarded as the most important principle, and justice was the least important 
one. 
• The patient perspective appeared to be a key source of motivation among researchers. 
• Declarations of rights and religious parables were regarded as better examples of moral 














• Cost benefit analysis was considered an important part of ethical reflection regarding 
EPIONE. 
• There was a slight difference in how the responders ranked ideas on ordinary morality and the 
way they ranked the same ideas regarding EPIONE. The latter set of ranking values viewed 
practical accountability higher than the former set. 
• The oversight and ethical assessment of EPIONE was satisfactory, but there were also 
frustrations and doubts about parts of the processes (especially the work of certain 
committees). 
• Everyone believed that EPIONE has ‘major’ or ‘minor, but important’ ethical implications. 
The comments also suggested that some do take an active interest in ethical issues. 
The cohort of the survey was too small to make any reliable statistical analysis, and therefore it cannot 
provide any valid claims. However, the answers can still offer dependable information on the small 
scale of the EPIONE case. As such, it could serve its purpose of facilitating the basis for further 
ethical deliberation amongst the participants. 
 
Workshop 
The IEA facilitated a workshop on ethics for the partners in EPIONE. The participants in the 
workshop were the same people and represented partners as had attended the lecture on ethics the day 
before. The workshop lasted for 90 minutes. 
The workshop was initiated and managed by the IEA and executed as a round table discussion 
between all of the participants. Everyone was active, and approximately half of the participants, 
representing eight different partners, spoke on more than one occasion. In the beginning of the 
session, the IEA spoke some but became quieter as the session went on. This silence was performed 













To set the stage, the IEA provided the participants with a brief brush up on some normative positions 
and the bioethical principals, both the American and the European ones, and some principals for 
scientific research. The IEA also illustrated the set of question frameworks discussed earlier and 
applied it to the practice of informed consent. The participants were asked to reflect and elaborate on 
the themes of autonomy, commercialization, precaution and humanity by using the set of questions 
and a problem-oriented approach. 
Several issues were discussed in the workshop. Very few led to open debate; one of these was on the 
issue of using healthy subjects for research experiments. The general impression was that each issue 
was addressed by offering the participants a) principal statements on the issue; b) experiences of the 
issue or similar kinds; and/or c) deliberations on the issue that included the use of normative theories 
and justifications and reasons for values and principals. 
Some of the main points from the workshop session were: 
• Benefits are important! We do what we do to help patients and reduce suffering. First are the 
medical benefits, but benefits for society or humanity at large are also part of the equation. 
• Patients are vulnerable and have needs we try to meet. The patents are also brave and most 
generous as they volunteer for the needs for research purposes. 
• Principals are good but also theoretical and abstract. The task of conceptualizing them into 
actions and attitudes is difficult and comes with experience. For example, applying a princip le 
of justice means being impartial and being aware of inclusion and accessibility for patients, 
and applying a precautionary principle means always looking for alternatives that lower the 
risks and negative side effects. 
• Transhumanism is mostly science fiction, but it is important for the public to understand that 














normality, but that in itself is not unnatural, but on the contrary most natural for societies to 
do. 
• When speaking with the media, we would like to have arguments. We get caught or trapped 
in the ethics and it would be very nice to have the ability to reply with a well-structured bottom 
line claim. 
• Ethical committees are here to stay and should ensure that both the public perspective and the 
patient’s perspective are represented and respected. 
• Our kind of research is embedded in the medical technical industry. It is a part of that industry, 
that is just the way it is, and if it was not, we probably could not do what we do. 
• Technical trails that do not lead to finished products are difficult to handle when recruiting 
and evaluating patient participation. Here, most thought that to be explicit about it and allow 
for voluntary participation is the way to go. However, others were not convinced. 
The IEA and the EPIONE management evaluated the workshop as successful. Many relevant issues 
were addressed, and most participants demonstrated well-informed and skilled reasoning on the 
matters. Some participants were less interested, and some comments were slightly hostile and 
dismissive of the ethical perspective. However, that is also part of the collective and shared 
deliberation that the workshop represents and facilitates. It was clear that many took the opportunity 
to talk about ethical issues, not to debate or solve them, but mostly to formulate and ventilate ideas 
and experiences. In this sense, the session worked as a form of peer-learning exchange. 
The ethical perspective remains, by most, to be in the form of an add-on and not a naturally integrated 
part. The comments were often clearly divided between a theoretical, academic formulation and a 
regular practical comment. The former being regarded as correct medical ethics, and the latter as just 
natural, not truly having anything to do with medical ethics, partially because the interdisciplinary 














ethical articulation of principals, regulations and patient perspectives, and the informal practices and 
subjective or common moral opinions is probably too ambitious of a task for a 90-minute session. 




As part of the regulatory role, the IEA observed the sessions on Exploitation and Disseminat ion 
during the EPIONE partner meeting in Montpellier on the 29th-30th of November 2016. In the 
sessions, the medical tech company Novosense and all partners participated. The purpose of the 
observation was for the IEA to investigate how moral issues appear and how they are dealt with when 
they are not explicitly addressed as ethical issues. This could be issues of unintended consequences, 
following procedures, communication failures or misunderstandings, cooperation and coordination 
of joint ventures, and respecting patients (also when they are not present). 
The observation revealed that the partners were aware of and addressed the following interest ing 
issues: 
1. Reporting all results, and not withholding results from one another. 
2. Agreeing on publication strategies. 
3. Coordinating and acknowledging the use of each other’s data. 
4. Respecting deadlines. 
5. All partners committing to the project. 
6. Harmonizing data collection. 
7. The use of data according to the agreed upon method, and the improper collection of data. 
8. Seeking ethical approval when changes to surveys are made. 













10. Overcoming practical problems, such as accidentally deleted files in Dropbox. 
All these issues include ethical considerations that constitute the guiding principles and values of the 
research project. These include a) respecting collaborative decisions; b) following and knowing the 
laws and regulations that apply; c) taking responsibility; d) trusting each other; e) acting for the benefit 
of all; and e) open and honest participation. The observation showed that these issues were actual 
issues in EPIONE and that the partners were addressing them and dealing with them to the best of 
their abilities. 
The observation also revealed that language is an unresolved and unattended obstacle for projects 
such as EPIONE. Everyone is not equally comfortable in speaking English. It is commonly assumed 
that scientists are competent English speakers, but that is not necessarily the case. We should 
recognize this fact, not ignore it, and be open about our linguistic abilities, and not pretend as if 
everyone fully understands and can expresses themselves in English. Even if one can, one can be 
uncomfortable or just out of practice in doing so. This is a problem of communication, but it certainly 
has moral consequences (misunderstandings, inequities, distrust, etc.) for interpersonal relationships 
such as in research collaborations. 
 
Interview 
To include the patient perspective, the IEA conducted an interview with one of the participat ing 
patients in EPIONE. The interview was set up with a volunteer subject at Aalborg University. The 
patient, when asked, voluntarily accepted the interview. The patient was in the final phase of his 
participation. All other information about the patient will not be revealed, since it does not have any 
impact on the purpose of the interview. The patient shall remain anonymous. 
The interview was prepared as a semi-structured interview, ensuring that the IEA was able to get 














lasted approximately 30 minutes, and present during the interview were the IEA (interviewer), the 
patient (interviewee), and associate professor Lontis and a research assistant (both silent during the 
interview). 
During the interview, five different themes were covered. These were a) reasons for participation; b) 
the conduct and conditions during trials; c) the benefits of participation; d) medical priorities; and e) 
transhumanism. These themes were meant to cover both the personal story and the more general 
issues, as well as to evaluate the recruiting process. 
The patient had the following comments, concerns and reasons: 
1. He wanted to participate, as soon as he heard about it an he felt that he needed to 
participate. 
2. He had knowledge of previous similar research and knew some of the researchers 
beforehand 
3. His main motivation for participation was to obtain a better life. 
4. He believed that he received all relevant information and he received the necessary help 
to understand them. 
5. He stated that he was very well taken care of. 
6. He trusted the researchers and experienced “good chemistry” with them. 
7. He was happy with the outcomes of the research project 
8. He experienced less pain and no major side effects. 
9. He felt that he had, during the process, come to learn and understand his pain better, which 
also helped him deal with his daily life. 
10. He supported this kind of research and development of novel medical treatmenst, since he 













11. He believed that if Aalborg University did not do the research, someone else would have 
carried it out and the he would lose out. 
12. For the price of this treatment, many other patients with other deceases or difficulties could 
have benefitted. But he did not approve of that argument, since the resources are not taken 
from one medical pursuit and given to another. He claimed that it is not the same resources. 
13. He did not think of himself as a transhuman or something comparable to that. 
14. He believed that ‘’technology is simply a tool that we use to achieve good things’’. 
15. In this case the researcher just imitates what the natural body already does. In that sense, 
although it is technology, it is simply natural. 
It is fascinating that the issue of transhumanism versus natural humanity was not a concern at all. 
With that in mind, and adding the same thoughts on the issue that the researchers addressed, it seemed 
that this issue of transhumanism was more a theoretical or popular media concern than it was an actual 
part of comprehension of the research and the possible treatment. 
The effect of ‘’getting to know one’s pain’’, and ‘’better handling it’’ indicates that the EPIONE 
project managed to go beyond just about making a product that functions and also touched upon 
something that interacted with the patient’s life. It is important for researchers to respect and 
acknowledge these facts, both when it has positive consequences but also in cases where the 
consequences are negative. 
Obviously, this patient was very pleased with the process. Taking the success of the device and the 
medical benefits aside, other things also mattered in building and maintain a good relationship is an 
apparent factor in success. The trust and good chemistry arose from 1) taking the time with the patient, 
showing respect and acknowledgement, 2) understanding that the work was with the patient, not on 
the patient, 3) recognizing that the researchers and the patient both used each other, but not letting 














In relation to financical issues, medical priorities and research possibilities, the patient was less 
convincing. Obviously, he was happy about the opportunity to be part of the project and enjoyed the 
benefits, but it is hardly a qualified utilitarian argument. There is certainly something right about the 
resources not being comparable. It is not one bag of money. However, from a public or more neutral 
point of view, the research and possible treatment was not motivated by immediate benefits, but, apart 
from the epistemic motivations, from a hope of a possible treatment becoming available in the future. 
However, like among the researchers themselves, there is a slight reluctance for discussing or 
questioning this issue of resources, of a finical cost-benefit analysis if you will. The costs is accepted 


















Methodological considerations  
It was clear that the task of ethics in EPIONE had several different aspects to consider. There were 
some regulations that needed to be followed and some assessment that needed to be evaluated. There 
were also demands for awareness and a more deliberative approach, as well as perhaps an interna l 
need for reflection. The IEA – the ethicist – had parts to play in this, but in many ways EPIONE – 
the researchers – were the important and active participants. The choice of an action research 
framework for the ethical activities enabled us to engage on these fronts and with these players, as a 
mean to create an environment for the ethics similar to an interdisciplinary learning progression.  
We did see the ethics of EPIONE being integrated into the science of EPIONE, through collective 
activities as well as through a thicker and thicker involvement, mirroring both a progression along a 
line from awareness to reflection, as well as a deliberative interplay between the abstract / theoretica l 
and the more hands-on practises and experiences. The activities were creating a unity and a linier 
development to some extent, drawing on the learning process and outcome from each other, but this 
could have been better emphasized and also more fruitfully explored.  
 
The IEA dual role as both regulatory and advisory became increasingly apparent during the course of 
the project. These two roles are not always compatible, but to be aware of them and the difference 
between them are important if the ethicist should have an integrated part to play in scientific research.  
The regulatory role is important because it enables ‘the other’, those not represented in the research 
or by the research, to have a voice and a say in the development, the means and the ends, of the 
research. This in turn is important to connect scientific activities and values with them of the society 













in the case of EPIONE, were the society is not represented by a single nation or a homogenetic culture, 
but by an international community and a heterogenetic culture. In such cases the expressed and 
evaluated regulation is important both as rules to follow and respect, and as rules allowing for some 
leniency and range of interpretation.   
The advisory role is important because this is where the integration takes place between the ethical 
and the scientific research. Whether it is in the form of a provider of theories and interpreter of 
concepts, or as a partner in a dialectic exchange, or as guidance in an explorative pursuit, the advisory 
role is one which both makes the ethics familiar and that empowers the more abstract needs and 
unfamiliar considerations. In this way the advisory role really becomes the tool of the interdisciplinary 
approach, in practise often as the problem initiator.            
 
Ethical reflections on the conducted research 
 
A research project like EPIONE is obviously almost constantly under some form of ethical scrutiny 
and assessment. These forms of evaluations and considerations target the interface between politics, 
society and science, and try to ensure the development of a sustainable future in which science and 
technology contribute with desirable consequences in a responsible fashion30. This is one way of 
comprehending the ethical perspective in and on EPIONE. However – the researcher – also enlighten 
us on another perspective, that of the researcher him/herself. Our action research framework, with the 
interdisciplinary learning qualification, also tried to address this issue; i.e. the issue of facilitating an 
ethical progress within and amongst the EPIONE itself, to somehow integrate moral philosophy / 
ethics into the scientific project of EPIONE.       
Moral philosophy is the philosophical, reflective study of certain values that concern human 














values informs people’s lives, directly in deciding what to do, and in their comments and judgements 
on people and actions, including their own. People try, in varying degrees, to shape their lives by 
reference to such values”31. Scientific researchers are also engaged by such value reflections, and 
they are recognizable in articulated norms and acclaimed practices, such as the famous CUDOS 
standard32. As science is increasingly regarded in light of its capacity to interact with society, the 
deliberation on research values is even further articulated: 
“The establishment of high standards, to judge our work by, and the duty constantly to raise these 
standards by hard work, are both indispensable. At the same time, we must constantly remind 
ourselves (especially in connection with the application of science) of the finitude and fallibility of 
our knowledge and the infinity of our ignorance.”33 
By now the researchers’ reflective study of certain values is an inevitable part of scientific research, 
allowing, as seen, the establishment of a connection between the values of research and the values of 
society. In this the scientist – the researcher – is in some way asked to do moral philosophy. It is a 
daunting task, but our case of EPIONE did see these reflections turn up and express themselves in 
different recognisable themes, such as patient perspectives, use of resources, the fear and hope of 
transhumanism and so on. The idea of an ethical progress, from awareness to reflection, was also 
present in terms of the activities provide, from the simple survey to the peer-learning and dialectic 
exchange of the workshop. Although it is difficult to actually document and evaluate such a reflection, 
especially if it is – as intended – carried from the activities into the normal practise, it is fair to say 
that the awareness was unavoidable and the articulation of ethics in EPIONE as least manifested itself 
as an conception of responsibility.   
“Perhaps when all the world is happy, calm and rational all questions can be perused, if there would 













any other human being, cannot escape his moral responsibility, especially his responsibility to bring 






It is our opinion that, even though there are good reasons for further theoretical exploration of values 
and methods, and for further deliberation on interesting issues, overall the case of the EPIONE project 
has clearly demonstrated a comprehensible framework and strategy of an adequate ethical approach, 
including assessment as well as reflection, to and within research and development of non-CE marked 
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